tiprankstipranks
Advertisement
Advertisement

PLRX Stock Latest News

Pliant Therapeutics Launches New $50 Million ATM Program
Company AnnouncementsPliant Therapeutics Launches New $50 Million ATM Program
6d ago
8K
PLRX
Pliant Therapeutics files $300M mixed securities shelf
PremiumThe Fly
Pliant Therapeutics files $300M mixed securities shelf
6d ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
PremiumThe Fly
Pliant Therapeutics price target lowered to $3 from $4 at Canaccord
24d ago
PLRX
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
PremiumCompany Announcements
How Shareholder Activism Could Disrupt Pliant Therapeutics’ Strategy, Costs, and Stock Performance
24d ago
PLRX
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
PremiumThe Fly
Pliant Therapeutics price target lowered to $3 from $4 at Piper Sandler
25d ago
PLRX
Pliant Therapeutics reports Q4 EPS (38c), consensus (38c)
PremiumThe FlyPliant Therapeutics reports Q4 EPS (38c), consensus (38c)
26d ago
PLRX
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
Premium
Company Announcements
Pliant Therapeutics Extends Stockholder Rights Agreement Expiration
1M ago
8K
PLRX
PLRX Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PLRX Earnings this Week: How Will it Perform?
1M ago
PLRX
Pliant Therapeutics Appoints Minnie Kuo as COO
PremiumCompany Announcements
Pliant Therapeutics Appoints Minnie Kuo as COO
4M ago
8K
PLRX
Pliant Therapeutics Announces Departure of Chief Medical Officer
PremiumCompany Announcements
Pliant Therapeutics Announces Departure of Chief Medical Officer
4M ago
8K
PLRX
Pliant Therapeutics announces interim data from PLN-101095
PremiumThe Fly
Pliant Therapeutics announces interim data from PLN-101095
4M ago
PLRX
Pliant Therapeutics Reports Improved Q3 2025 Results
PremiumCompany Announcements
Pliant Therapeutics Reports Improved Q3 2025 Results
5M ago
PLRX
Pliant Therapeutics reports Q3 EPS (43c), consensus (52c)
PremiumThe FlyPliant Therapeutics reports Q3 EPS (43c), consensus (52c)
5M ago
PLRX
Pliant Therapeutics Announces CBO Hans Hull’s Resignation
Premium
Company Announcements
Pliant Therapeutics Announces CBO Hans Hull’s Resignation
5M ago
8K
PLRX
Pliant Therapeutics Settles Loan with Oxford Finance
Premium
Company Announcements
Pliant Therapeutics Settles Loan with Oxford Finance
6M ago
8K
PLRX
Buy/Sell: Wall Street’s top 10 stock calls this week
PremiumThe Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
6M ago
MU
AMD
Align downgraded, NetEase upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Align downgraded, NetEase upgraded: Wall Street’s top analyst calls
6M ago
ABT
MOS
Pliant Therapeutics downgraded to Underweight from Neutral at JPMorgan
PremiumThe Fly
Pliant Therapeutics downgraded to Underweight from Neutral at JPMorgan
6M ago
PLRX
Pliant Therapeutics Reports Q2 2025 Financial Results
PremiumCompany Announcements
Pliant Therapeutics Reports Q2 2025 Financial Results
8M ago
PLRX
Pliant Therapeutics price target raised to $1.70 from $1.50 at Citi
PremiumThe FlyPliant Therapeutics price target raised to $1.70 from $1.50 at Citi
8M ago
PLRX
Pliant Therapeutics price target lowered to $4 from $17 at Piper Sandler
Premium
The Fly
Pliant Therapeutics price target lowered to $4 from $17 at Piper Sandler
8M ago
PLRX
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c)
Premium
The Fly
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c)
8M ago
PLRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >